BOSTON SCIENTIFIC CORPORATION Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
BOSTON SCIENTIFIC CORPORATION (BSX) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $14.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2018-12-31 was $90.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2018-06-30 was $303.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2010-12-31 was -$77.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2010-09-30 was $42.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $14.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $14.00M, a 1300.00% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $1.00M, a 50.00% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 3 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 6 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 9 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $14.00M 10-K · filed 2026-02-17 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 | ||||
| 2023-12-31 | $14.00M 10-K · filed 2026-02-17 | ||||
| 2022-12-31 | $1.00M 10-K · filed 2025-02-18 | ||||
| 2021-12-31 | $2.00M 10-K · filed 2024-02-20 | ||||
| 2020-12-31 | $27.00M 10-K · filed 2023-02-23 | ||||
| 2019-12-31 | $4.00M 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $90.00M 10-K · filed 2021-02-23 | $459.00M 10-K · filed 2021-02-23 | |||
| 2018-06-30 | $303.00M 10-K · filed 2021-02-23 | ||||
| 2017-12-31 | $2.00M 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $3.00M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $18.00M 10-K · filed 2018-02-20 | -$18.00M 10-K · filed 2016-02-24 | |||
| 2014-12-31 | $5.00M 10-K · filed 2017-02-23 | -$5.00M 10-K · filed 2015-02-25 | |||
| 2013-12-31 | -$15.00M 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | -$1.00M 10-K · filed 2015-02-25 | ||||
| 2011-12-31 | -$3.00M 10-K · filed 2014-02-26 | -$42.00M 10-K · filed 2012-02-17 | |||
| 2010-12-31 | -$77.00M derived: 8-K 12 month − 10-Q 9 month · filed 2013-05-29 | -$35.00M derived: sum of 2 quarters · filed 2013-05-29 | -$35.00M 8-K · filed 2013-05-29 | $35.00M 10-K · filed 2011-02-17 | |
| 2010-09-30 | $42.00M 10-Q · filed 2010-11-05 | $42.00M 10-Q · filed 2010-11-05 | |||
| 2009-12-31 | -$65.00M 10-K · filed 2012-02-17 | $65.00M 10-K · filed 2011-02-17 | |||
| 2008-12-31 | $82.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |